Children with HIV on dolutegravir (Tivicay)-based antiretroviral therapy (ART) can safely receive the standard prophylactic ...

Antiretroviral therapies (ART) against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many of them are aging in good health.

Dar es Salaam. Health practitioners in Tanzania are optimistic after the official registration of Lenacapavir, a long-acting ...

As Uganda rolls out mandatory nationwide screening of newborns for sickle cell disease this month, a gene therapy celebrated in the United States and Europe remains financially out of reach for most ...

Immunocore reports fourth quarter and full year 2025 financial results and provides a business update KIMMTRAK (tebentafusp-tebn) Q4 net sales ...

As Uganda rolls out mandatory nationwide screening of newborns for sickle cell disease this month, a gene therapy celebrated in the United States and Europe remains financially out of reach for most ...

The Supreme Court seeks information on the cost and availability of Nucleic Acid Amplification Testing (NAT) in government hospitals to detect HIV, hepatitis, and other transfusion transmissible infec ...

SC seeks details on cost, availability of NAT in hospital to prevent transfusion related infection| India News ...

Researchers from Brown University and the University of Rochester will lead a multi-institution project to test whether ...

A new study has overcome a long-standing challenge-how to isolate and study elusive HIV-infected cells called authentic reservoir clones (ARCs) that evade the immune system, making the disease ...

One-third of children with HIV who received very early ART had no detectable virus in their body for at least 12 weeks after stopping treatment, according to study findings. It was another sign that ...

GLP-1 receptor agonists improve glycemic control and weight while reducing cardiovascular events, with tolerability limited by gastrointestinal adverse effects requiring gradual dose escalation.